PROSTATE cancer treatmentTREATMENT effectivenessDRUG side effectsETIOLOGY of diseasesQUALITY of lifeProstate Cancer UK fights to help more men survive prostate cancer and enjoy a better quality of life. We support men who are confronting prostate cancer, prostate diseases and the effects of treatment ...
In July this year we started raising awareness within the darting community For Prostate cancer UK. We created a darts-Pcuk shirt and have now sold over 600. We, darts players, darts enthusiasts have joined together to raise money for this great & needy charity. You'll see our team fundra...
Latest Conference Coverage HER2+ Early Breast Cancer: Tailoring Therapy in the Era of Expanding Options PF-07248144 Plus Fulvestrant Is Safe, Active in Pretreated ER+/HER2– Metastatic Breast Cancer Updated Data Further Support KEYNOTE-522 Regimen as SOC in High-Risk, Early-Stage TNBC Elacestr...
We would both like to say a massive thank you to everyone who has followed this blog, encouraged and helped us along the way, and a special thanks to those who donated to Prostate Cancer UK. Knowing we had such amazing support made a huge difference when things got tough. We ended up ...
Clark-Drain embark on the Keyline Millionaire Rally, all in support of Prostate Cancer UK. Follow the journey for a great cause!
Prostate Cancer UK estimates that updating the NHS guidance, and implementing plans for raising awareness about the changes, could be delivered in just twelve months. Amy Rylance, Assistant Director of Health Improvement at Prostate Cancer UK, said, "Leaving men in the dark about their risk means...
UK's largest Centre for Prostate Brachytherapy with +2000 successful treatments for prostate cancer without the need for radical surgery
Oncology Conferences 2024: The worlds largest Cancer Research Conference, Join the Breast Cancer Conferences at London, UK
Prostate cancer is the second most common cause of cancer deaths in men in the UK with more than 47,000 men diagnosed every year — that’s around 130 every day. Men over 50 are more likely to develop prostate cancer, and the risk increases with age. Between 70 and 74 is the most ...
“These data clearly support the prognostic power of the ConfirmMDx genes. The addition of a risk score for ConfirmMDx methylated patients, which enhances the test’s positive predictive value, will provide deeper insights into a patient’s risk for undetected clinically significant cancer,” s...